SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001787306-22-000032
Filing Date
2022-05-05
Accepted
2022-05-05 16:09:41
Documents
68
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arqt-20220331.htm   iXBRL 10-Q 1140276
2 RULE 13A-14(A) CERTIFICATION exhibit311ceoq12022.htm EX-31.1 10802
3 RULE 13A-14(A) CERTIFICATION exhibit312cfoq12022.htm EX-31.2 10777
4 SECTION 1350 CERTIFICATIONS exhibit321ceocfoq12022.htm EX-32.1 7110
  Complete submission text file 0001787306-22-000032.txt   6309851

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20220331.xsd EX-101.SCH 45063
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20220331_cal.xml EX-101.CAL 57191
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20220331_def.xml EX-101.DEF 239397
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20220331_lab.xml EX-101.LAB 602338
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20220331_pre.xml EX-101.PRE 403288
62 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20220331_htm.xml XML 994542
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39186 | Film No.: 22896303
SIC: 2834 Pharmaceutical Preparations